<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23644889</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1422-0067</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Chebulagic acid, a hydrolyzable tannin, exhibited antiviral activity in vitro and in vivo against human enterovirus 71.</ArticleTitle><Pagination><StartPage>9618</StartPage><EndPage>9627</EndPage><MedlinePgn>9618-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms14059618</ELocationID><Abstract><AbstractText>Human enterovirus 71 is one of the major causative agents of hand, foot and mouth disease in children under six years of age. Presently, no vaccines or antiviral drugs have been clinically available to employ against EV71. In this study, we demonstrate that treatment with chebulagic acid reduced the viral cytopathic effect on rhabdomyosarcoma cells with an IC50 of 12.5 &#x3bc;g/mL. The utilization of the chebulagic acid treatment on mice challenged with a lethal dose of enterovirus 71 was able to efficiently reduce mortality and relieve clinical symptoms through the inhibition of viral replication. Chebulagic acid may represent a potential therapeutic agent to control infections to enterovirus 71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, PUMC, Beijing 100021, China. zhanglf@cnilas.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiu</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoying</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yanfeng</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lianfeng</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001578">Benzopyrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047348">Hydrolyzable Tannins</NameOfSubstance></Chemical><Chemical><RegistryNumber>23094-71-5</RegistryNumber><NameOfSubstance UI="C076178">chebulagic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Int J Mol Sci. 2021 Aug 06;22(16):8443. doi: 10.3390/ijms22168443</RefSource><PMID Version="1">34445810</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001578" MajorTopicYN="N">Benzopyrans</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="N">Glucosides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047348" MajorTopicYN="N">Hydrolyzable Tannins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23644889</ArticleId><ArticleId IdType="pmc">PMC3676802</ArticleId><ArticleId IdType="doi">10.3390/ijms14059618</ArticleId><ArticleId IdType="pii">ijms14059618</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today. 2010;15:1041&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., Lu J., Kung H., He M.L. The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 2011;37:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.N., Li X.Y., Fan X.X., Ma C.M., Qin C., Zhang L.F. Adoptive transfer of macrophages from adult mice reduces mortality in mice infected with human enterovirus 71. Arch. Virol. 2013;158:387&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">23065110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Zhang T., Hu Y.F., Wang X.F., Du J., Li Y.F., Sun S.X., Sun X.H., Li Z.F., Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol. J. 2011;8 doi: 10.1186/1743-422X-8-508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-508</ArticleId><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.N., Zhao D.D., Gao B., Zhong K., Zhu R.X., Zhang Y., Xie W.J., Jia L.R., Gao H. Anti-hyperglycemic effect of chebulagic acid from the fruits of Terminalia chebula. Retz. Int. J. Mol. Sci. 2012;13:6320&#x2013;6333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3382786</ArticleId><ArticleId IdType="pubmed">22754367</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.X., Yu S.J., Liu D., Proksch P., Lin W.H. Inhibitory effects of polyphenols toward HCV from the mangrove plant Excoecaria agallocha L. Bioorg. Med. Chem. Lett. 2012;22:1099&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">22196120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L.T., Chen T.Y., Chung C.Y., Noyce R.S., Grindley T.B., McCormick C., Lin T.C., Wang G.H., Lin C.C., Richardson C.D. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol. 2011;85:4386&#x2013;4398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126266</ArticleId><ArticleId IdType="pubmed">21307190</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka G., Nishioka I., Nishizawa M., Yamagishi T., Kashiwada Y., Dutschman G.E., Bodner A.J., Kilkuskie R.E., Cheng Y.C., Lee K.H. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. J. Nat. Prod. 1990;53:587&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">1698933</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.N., Yang Y.J., Xu Y.F., Ma C.M., Qin C., Zhang L.F. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Viol. J. 2011;8:483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3212826</ArticleId><ArticleId IdType="pubmed">22029605</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Xiu J.H., Zhang X., Zhang L.F., Yan K., Qin C., Liu J.N. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370&#x2013;10376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6268984</ArticleId><ArticleId IdType="pubmed">22932217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang L.C., Ng L.T., Cheng P.W., Chiang W., Lin C.C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin. Exp. Pharmacol. Physiol. 2005;32:811&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">16173941</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.J., Lim C.H., Song J.H., Baek S.H., Kwon D.H. Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine. 2009;16:35&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">19097770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Leu Y.L., Chiu D.T. Antiviral effect of epigallocatechin gallate on enterovirus 71. J. Agric. Food. Chem. 2009;57:6140&#x2013;6147.</Citation><ArticleIdList><ArticleId IdType="pubmed">19537794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.W., Wu C.F., Hsiao N.W., Chang C.Y., Li S.W., Wan L., Lin Y.J., Lin W.Y. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int. J. Antimicrob. Agents. 2008;32:355&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="pubmed">18701259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q.C., Wang Y., Liu Y.P., Zhang R.Q., Li X., Su W.H., Long F., Luo X.D., Peng T. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. Eur. J. Pharm. Sci. 2011;44:392&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Zhang L.F., Fan X.X., Qin C., Liu J.N. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. Bioorg. Med. Chem. Lett. 2012;22:2209&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pubmed">22342145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Xiu J.H., Zhang L.F., Qin C., Liu J.N. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo. Phytomedicine. 2012;20:67&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">23146421</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzzini P., Arapitsas P., Goretti M., Branda E., Turchetti B., Pinelli P., Ieri F., Romani A. Antimicrobial and antiviral activity of hydrolysable tannins. Mini. Rev. Med. Chem. 2008;8:1179&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">18855732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada S., Kataoka T., Woo J.T., Yamada A., Yoshida T., Nishimura T., Otake N., Nagai K. Immunosuppressive effects of gallic acid and chebulagic acid on CTL-mediated cytotoxicity. Biol. Pharm. Bull. 1997;20:1017&#x2013;1019.</Citation><ArticleIdList><ArticleId IdType="pubmed">9331989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.I., Hyun P.M., Kim S.H., Kim K.S., Lee S.K., Kim B.S., Maeng P.J., Lim J.S. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library. Arthritis Rheum. 2005;52:345&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">15641090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>